What are the TI-RADS (Thyroid Imaging Reporting and Data System) criteria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The Thyroid Imaging Reporting and Data System (TIRADS) is a crucial tool for risk stratification of thyroid nodules detected on ultrasound, and it is based on extensive data collected over the past two decades on US assessment of TNs, as stated in the study by 1. The TIRADS system assigns points based on five ultrasound features: composition, echogenicity, shape, margin, and echogenic foci.

  • Composition can be cystic (0 points), spongiform (0 points), mixed cystic-solid (1 point), or solid (2 points).
  • Echogenicity is scored as anechoic (0 points), hyperechoic/isoechoic (1 point), hypoechoic (2 points), or very hypoechoic (3 points).
  • Shape is either wider-than-tall (0 points) or taller-than-wide (3 points).
  • Margins can be smooth (0 points), ill-defined (0 points), lobulated/irregular (2 points), or extra-thyroidal extension (3 points).
  • Echogenic foci include none/large comet-tail artifacts (0 points), macrocalcifications (1 point), peripheral calcifications (2 points), or punctate echogenic foci (3 points). The total point score determines the TIRADS level (TR1-TR5) and subsequent management, with higher scores indicating greater risk of malignancy and lower thresholds for biopsy, as supported by the study by 1. The primary goal of TIRADS is to standardize the terminology used in thyroid US reports and minimize unnecessary fine needle aspiration (FNA), such as those resulting in benign/nonneoplastic cytology, as mentioned in the study by 1. The system helps standardize thyroid nodule evaluation and reduces unnecessary biopsies while ensuring potentially malignant nodules are appropriately investigated, as stated in the study by 1. In clinical practice, the TIRADS system is used in conjunction with other guidelines, such as the American Thyroid Association guidelines, to classify differentiated thyroid carcinomas (DTCs) as low-, intermediate-, and high-risk, and to determine the need for radioiodine treatment and tailor postoperative management for DTC, as mentioned in the study by 1.

From the Research

TIRADS Criteria

The Thyroid Imaging Reporting and Data System (TIRADS) is a standardized approach for the risk stratification of thyroid nodules. The criteria for TIRADS include:

  • Scoring the number or combination of suspicious ultrasound features to calculate the risk of malignancy in thyroid nodules 2
  • Classification of nodules into different categories based on their ultrasound features, with recommendations for further diagnostic steps 3, 4
  • Use of a points-based approach to lead to clear management recommendations for nodules 5

TIRADS Categories

The TIRADS categories are used to stratify the risk of malignancy in thyroid nodules. The categories include:

  • Category 5: highly suspicious nodules with a higher risk of malignancy 6
  • Category 4: suspicious nodules with a moderate risk of malignancy 3
  • Category 3: nodules with a low risk of malignancy 3
  • Category 2: benign nodules with a very low risk of malignancy 3
  • Category 1: non-diagnostic or incomplete ultrasound evaluation 4

Diagnostic Performance of TIRADS

The diagnostic performance of TIRADS has been evaluated in several studies. The results show that:

  • TIRADS has a high sensitivity and negative predictive value for the diagnosis of thyroid carcinoma 3
  • The prevalence of malignancy rises with increasing category levels of TIRADS 2
  • TIRADS seems to be a promising tool to reliably assess the risk of malignancy of small thyroid nodules 2
  • The highest negative predictive value was found for ACR TI-RADS and the highest positive predictive value for Kwak-TIRADS 2

Related Questions

What is the management for a thyroid anechoic mass with a TI-RADS (Thyroid Imaging, Reporting and Data System) score of 2?
When to perform a biopsy for thyroid vs breast masses based on TI-RADS (Thyroid Imaging Reporting and Data System) and BI-RADS (Breast Imaging Reporting and Data System) according to NCCN (National Comprehensive Cancer Network) guidelines?
Should I order a thyroid ultrasound-guided biopsy for a patient with a history of thyroid nodules and a TI-RADS (Thyroid Imaging, Reporting and Data System) 4 classification?
What is the recommended course of action for a patient with a maximal TI-RADS (Thyroid Imaging Reporting and Data System) 5 nodule detected on thyroid ultrasound?
What are the next steps for a patient with a maximal TI-RADS (Thyroid Imaging Reporting and Data System) 5 nodule found on thyroid ultrasound?
Should a patient with Neuromyelitis Optica (NMO) be evaluated for other autoimmune diseases?
What is the treatment for stasis dermatitis using Clobetasol (clobetasol propionate) 0.05%?
What is the efficacy of Venlafaxine (Effexor) for treating postpartum depression?
Why would a surgeon not resect a large neoplasm (tumor)?
Which thyroid nodules would be indicated for biopsy in a patient with hypermetabolic thyroid nodules, given the presence of multinodular goiter and specific nodule characteristics?
What is the cause of hernia in an obese middle-aged lady with symptoms of Gastroesophageal Reflux Disease (GORD), where the gastroesophageal junction is above the level of the diaphragm?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.